The group’s principle activity is to develop site-specific biological systems using biofriendly linkers that selectively adhere to proteins, drugs, cells, and biomaterial surfaces in order to kickstart biology toward an intended outcome. Customers served by the group include orthopedics and cardiovascular. The group operates from United States.
